Does Roche need a biotech brain in the chairman’s office?

John Carroll It looks like Roche's top two picks for the role of chairman–both execs from the multinational field–have taken a pass on the job. And that has left at ...

Roche plows $105 million into training center to feed expansion of Swiss logistics plant

Eric Palmer Roche is building a $ 105 million training center at a key plant in the Swiss company's home country. FiercePharma News

Rumors of big Roche bid for Alexion cool as analysts weigh in

John Carroll At second glance, that big, prospective Roche offer to buy Alexion looks less and less likely to the market. FierceBiotech News

Roche may want Alexion, but is the price right?

Tracy Staton Roche may have the wherewithal to bid for Alexion and an appetite for the company's rare-disease drugs. But it might not have a stomach for the price. FiercePharma ...

Buzz: Why is Roche considering a big buyout of Alexion?

John Carroll Shares of the rare disease drug specialist Alexion spiked 18% this afternoon after Bloomberg reported that Roche has been putting out feelers to raise cash for a big buyout. ...

Buzz: Why is Roche considering a big buyout of Alexion?

John Carroll Shares of the rare disease drug specialist Alexion spiked 18% this afternoon after Bloomberg reported that Roche has been putting out feelers to raise cash for a big buyout. ...

Roche Scuttles Diabetes Drug After Clinical Trial Flops

esilverman In a setback to Roche, the drugmaker has ended a Phase III trial of a high-profile diabetes compound after a data and safety monitoring board determined there were ...

Roche scraps diabetes drug as pRED racks up another PhIII fiasco

John Carroll Once again, Roche's pRED group has a big Phase III snafu to answer for. The Basel-based R&D side of the pharma giant–distinct from the gRED operations at ...

Roche Stops Diabetes Trials Over Safety Concerns

barbara.lempert Roche halts investigation of aleglitazar following regular safety review of phase III trial BASEL, Switzerland, July 10, 2013 – Roche (SIX: RO, ROG; OTCQX: ...

Roche bids for broad use of HPV test to screen for cervical cancer

Tracy Staton Roche is aiming to make its human papillomavirus test a first-line diagnostic for cervical cancer, with a new FDA application for the Cobas HPV as a substitute for Pap ...

Who’s hiring in Big Pharma? Novartis, Roche, Sanofi top the list

Tracy Staton The world's biggest drugmakers are hiring–even in the U.S. and Europe. As Genetic Engineering & Biotechnology News numbers show, the three most ...

Roche, AstraZeneca join forces on precompetitive R&D initiative

John Carroll Roche and AstraZeneca have formed an unusual, precompetitive alliance designed to share vast stockpiles of compound data in order to improve their chances of success in ...
Page 5 of 7« First...34567
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS